We speculated that the discrepancy might be ascribed to the limited number of samples diagnosed with HER2 positivity in our study, and all HER2‐positive MBCs were mixed with infiltrating ductal carcinoma in previous reports.32 Here, ERBB2 is linked to invasive ductal breast carcinoma.